BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25638276)

  • 21. Cigarette smoke-induced lung endothelial apoptosis and emphysema are associated with impairment of FAK and eIF2α.
    Sakhatskyy P; Gabino Miranda GA; Newton J; Lee CG; Choudhary G; Vang A; Rounds S; Lu Q
    Microvasc Res; 2014 Jul; 94():80-9. PubMed ID: 24853558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Glucosylceramide in Lung Endothelial Cell Fate and Emphysema.
    Koike K; Berdyshev EV; Mikosz AM; Bronova IA; Bronoff AS; Jung JP; Beatman EL; Ni K; Cao D; Scruggs AK; Serban KA; Petrache I
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1113-1125. PubMed ID: 31265321
    [No Abstract]   [Full Text] [Related]  

  • 23. Progranulin protects lung epithelial cells from cigarette smoking-induced apoptosis.
    Lee KY; Park SY; Park S; Hong GH; Moon KA; Kim YS; Oh YM; Kwon HS; Kim TB; Moon HB; Cho YS
    Respirology; 2017 Aug; 22(6):1140-1148. PubMed ID: 28273689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cigarette Smoke-Induced Pulmonary Inflammation and Autophagy Are Attenuated in Ephx2-Deficient Mice.
    Li Y; Yu G; Yuan S; Tan C; Lian P; Fu L; Hou Q; Xu B; Wang H
    Inflammation; 2017 Apr; 40(2):497-510. PubMed ID: 28028752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema.
    Hirama N; Shibata Y; Otake K; Machiya J; Wada T; Inoue S; Abe S; Takabatake N; Sata M; Kubota I
    Respirology; 2007 Mar; 12(2):191-201. PubMed ID: 17298450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xeroderma Pigmentosum Group C Deficiency Alters Cigarette Smoke DNA Damage Cell Fate and Accelerates Emphysema Development.
    Sears CR; Zhou H; Justice MJ; Fisher AJ; Saliba J; Lamb I; Wicker J; Schweitzer KS; Petrache I
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):402-411. PubMed ID: 29111769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice.
    Bracke KR; D'hulst AI; Maes T; Demedts IK; Moerloose KB; Kuziel WA; Joos GF; Brusselle GG
    Clin Exp Allergy; 2007 Oct; 37(10):1467-79. PubMed ID: 17883726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced deposition of low-molecular-weight hyaluronan in lungs of cigarette smoke-exposed mice.
    Bracke KR; Dentener MA; Papakonstantinou E; Vernooy JH; Demoor T; Pauwels NS; Cleutjens J; van Suylen RJ; Joos GF; Brusselle GG; Wouters EF
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):753-61. PubMed ID: 19675307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptomic Analysis of Lung Tissue from Cigarette Smoke-Induced Emphysema Murine Models and Human Chronic Obstructive Pulmonary Disease Show Shared and Distinct Pathways.
    Yun JH; Morrow J; Owen CA; Qiu W; Glass K; Lao T; Jiang Z; Perrella MA; Silverman EK; Zhou X; Hersh CP
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):47-58. PubMed ID: 28248572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema.
    Reimann S; Fink L; Wilhelm J; Hoffmann J; Bednorz M; Seimetz M; Dessureault I; Troesser R; Ghanim B; Klepetko W; Seeger W; Weissmann N; Kwapiszewska G
    Respir Res; 2015 Oct; 16():127. PubMed ID: 26483185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage migration inhibitory factor is a novel determinant of cigarette smoke-induced lung damage.
    Fallica J; Boyer L; Kim B; Serebreni L; Varela L; Hamdan O; Wang L; Simms T; Damarla M; Kolb TM; Bucala R; Mitzner W; Hassoun PM; Damico R
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):94-103. PubMed ID: 24490973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Convergence: Lactosylceramide-Centric Signaling Pathways Induce Inflammation, Oxidative Stress, and Other Phenotypic Outcomes.
    Chatterjee S; Balram A; Li W
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the number of CD31
    Deng M; Li J; Gan Y; Chen Y; Chen P
    Int J Chron Obstruct Pulmon Dis; 2017; 12():861-872. PubMed ID: 28352167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysophospholipid Acyltransferase 9 Promotes Emphysema Formation via Platelet-activating Factor.
    Murano H; Inoue S; Hashidate-Yoshida T; Shindou H; Shimizu T; Otaki Y; Minegishi Y; Kitaoka T; Futakuchi M; Igarashi A; Nishiwaki M; Nemoto T; Sato M; Kobayashi M; Sato K; Hanawa T; Miyazaki O; Watanabe M
    Am J Respir Cell Mol Biol; 2024 Jun; 70(6):482-492. PubMed ID: 38377392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD.
    John-Schuster G; Hager K; Conlon TM; Irmler M; Beckers J; Eickelberg O; Yildirim AÖ
    Am J Physiol Lung Cell Mol Physiol; 2014 Nov; 307(9):L692-706. PubMed ID: 25128521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation of Z α1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema.
    Alam S; Li Z; Janciauskiene S; Mahadeva R
    Am J Respir Cell Mol Biol; 2011 Aug; 45(2):261-9. PubMed ID: 20971880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of glycosphingolipid-enriched lipid rafts in inflammatory responses.
    Iwabuchi K
    Front Biosci (Landmark Ed); 2015 Jan; 20(2):325-34. PubMed ID: 25553454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmenting autophagy for prognosis based intervention of COPD-pathophysiology.
    Bodas M; Vij N
    Respir Res; 2017 May; 18(1):83. PubMed ID: 28472967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema.
    D'hulst AI; Bracke KR; Maes T; De Bleecker JL; Pauwels RA; Joos GF; Brusselle GG
    Eur Respir J; 2006 Jul; 28(1):102-12. PubMed ID: 16540505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lactosylceramide-enriched Lipid Raft-mediated Infection Immunity].
    Iwabuchi K
    Med Mycol J; 2018; 59(3):J51-J61. PubMed ID: 30175814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.